priv.jpg
Privia Health to Participate in the William Blair Growth Stock Conference
May 30, 2024 09:26 ET | Privia Health Group, Inc.
Privia Health to Participate in the William Blair Growth Stock Conference
download.png
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau) for the Diagnosis of Progressive Supranuclear Palsy
May 20, 2024 08:00 ET | APRINOIA Therapeutics, Inc.
CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- APRINOIA Therapeutics (“Aprinoia” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics and precision...
cmi_logo.png
[Latest] Global Carbonated Beverages Market Size/Share Worth USD 771.3 Billion by 2033 at a 5.60% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 17, 2024 03:30 ET | Custom Market Insights
Austin, TX, USA, May 17, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Carbonated Beverages Market Size, Trends and Insights By Product Type (Cola...
Global Post-consumer Recycled Plastics Market
Post-consumer Recycled Plastics Market Analysis Report 2024, By Source (Bottles, Non-bottle Rigid), By Type (PP, PS, PE, PVC, PET) and Region
May 16, 2024 10:40 ET | Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Post-consumer Recycled Plastics Market Size, Share & Trends Analysis Report By Source (Bottles, Non-bottle Rigid), By Type (PP, PS, PE, PVC, PET),...
Global Pet Sitting Market
Pet Sitting Market Trends Analysis Report 2024-2030, Featuring A Place for Rover, Pets at Home, Wag! Group, PetBacker, Careguide, Fetch! Pet Care, Holidog, PetSmart, Dogtopia and Swifto
May 16, 2024 10:37 ET | Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Pet Sitting Market Size, Share & Trends Analysis Report By Pet Type (Dogs, Cats), By Service Type (Care Visits, Drop-in Visits), By Region, And...
cmi_logo.png
[Latest] Global Sports and Energy Drinks Market Size/Share Worth USD 150.22 Billion by 2033 at a 7.48% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 14, 2024 05:30 ET | Custom Market Insights
Austin, TX, USA, May 14, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Sports and Energy Drinks Market Size, Trends and Insights By Product Type (Sports...
cmi_logo.png
[Latest] Global Cancer Supportive Care Drugs Market Size/Share Worth USD 32,783.2 Billion by 2033 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 06, 2024 12:30 ET | Custom Market Insights
Austin, TX, USA, May 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Supportive Care Drugs Market Size, Trends and Insights By Drug Type...
Realtors®’ Charitabl
Realtors®’ Charitable Giving and Volunteering Increased Last Year
May 01, 2024 09:00 ET | National Association of Realtors®
WASHINGTON, May 01, 2024 (GLOBE NEWSWIRE) -- Key Highlights Nearly seven out of 10 (69%) Realtor® members at large volunteered monthly, typically spending eight hours volunteering each...
Figure 1*
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab
April 25, 2024 10:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
tiziana-logo.png
Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
April 23, 2024 07:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...